NCT06147895View on ClinicalTrials.gov

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

September 25, 2023

Study Completion Date

September 25, 2023

Conditions
Vaccine-Preventable DiseasesHepatitis B
Interventions
BIOLOGICAL

CVI-HBV-002

Investigational Product

Trial Locations (1)

13496

CHA University Bundang Medical Center, Seongnam-si

All Listed Sponsors
lead

CHA Vaccine Institute Co., Ltd.

INDUSTRY

NCT06147895 - A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine | Biotech Hunter | Biotech Hunter